In lung cancer, it has been reported that GLDC induces significant changes in glycolysis and glycine/serine metabolism, leading to changes in pyrimidine metabolism, thereby regulating the proliferation of non-small cell lung cancer cells. The gene discussed is GLDC; the disease is non-small cell lung carcinoma.